Understanding the phase behavior of pharmaceuticals is important for dosage form development and regulatory requirements, in particular after the incident with ritonavir. In the present paper, a comprehensive study of the solid-state phase behavior of cysteamine hydrochloride used in the treatment of radiation sickness, sickle cell anemia and nephropathic cystinosis, is presented employing (high-pressure) calorimetry, water vapor sorption, and X-ray diffraction as a function of temperature. A new crystal form (I2/a, form III) has been discovered and its structure has been solved by X-ray powder diffraction, while two other crystalline forms are already known. The relative thermodynamic stabilities of the commercial form I and of the newly discovered form III have been established; they possess an overall enantiotropic phase relationship, with form I stable at room temperature and form III stable above 37 °C. Its melting temperature was found at 67.3 ± 0.5 °C. Cysteamine hydrochloride is hygroscopic and immediately forms a concentrated saturated solution in water with a surprisingly high concentration of 47.5 mole% above a relative humidity of 35 %. No hydrate has been observed.
Introduction
Cysteamine hydrochloride, 2-aminoethanethiol hydrochloride (C2H7NS⋅HCl, M = 113.61 g mol -1 ) (Figure 1 ), is the salt formulation of the decarboxylated form of the amino acid cysteine and it is an important intermediate in the alternative pathway of taurine biosynthesis. 1, 2
Figure 1. Chemical structure of cysteamine hydrochloride
Besides its various pharmacological effects involving the immune-reactive somatostatin levels, the secretion of several pituitary hormones, the duodenal ulcer, and also protection against oxidizing radiation, it is known to be a post-toxicant therapeutic agent for hepatic necrosis. 1, 2 Clinically, cysteamine hydrochloride is used in the treatment nephropathic cystinosis, a rare autosomal recessive disease characterized by an excessive intra-lysosomal cystine accumulation due to a defect of the transport system in the lysosomal membrane. 3, 4 Cysteamine cleaves the disulfide bond with cystine to produce molecules that can be carried out of the lysosome by a lysine carrier and thus avoid the metabolic defect in cystinosis and cystinuria. 5 Recently, the European Commission has granted orphan designation to Lucane Pharma SA, France, for cysteamine hydrochloride for the treatment of cystinosis (EU/3/14/1314). Other treatments under study are against Huntington's disease, nonalcoholic fatty liver disease, malaria, and cancer. 3 Two crystal structures have been published in the literature; 6, 7 details can be found in Table   1 . A triclinic form was observed by single crystal X-ray diffraction at 145 K with crystals obtained from 1-butanol after two weeks of crystallization at 4°C (277 K). 6 According to the authors isopropanol and n-propanol could be employed too. 6 A monoclinic form was reported in 2010. 7 The crystal had been found in the commercial sample and measured as such by single crystal X-ray diffraction at 173 K. 7 No information on the phase relationships between these two solid forms has been provided. Lahiani-Skiba et al. mention a melting point for cysteamine hydrochloride of 70.2-70.7 °C (343.6 K) for a sample obtained from the Parisian hospitals without mentioning the crystal structure. 8 The melting data gathered by Scifinder® (30 April 2014) leads to an average melting point of 69.7 °C (342.8 K) ranging from 64 up to 72 °C. No phases have been specified. To facilitate the discussion below, the following nomenclature is proposed: form I, monoclinic structure, and form II, triclinic structure (Table 1) . To prepare a suitable dosage form, the physical properties of the active pharmaceutical ingredient are important information. As is clear from the foregoing, at least two phases exist for cysteamine hydrochloride; however, no information on their phase relationships has been reported, i.e. it is not known which of the two forms is the stable one at room temperature, because both structure determinations by X-ray have been carried out far below room temperature. In addition, little is known about the effect of humidity on cysteamine and whether this should be taken into account in the dosage form design. Therefore, in the present paper, a number of experimental approaches have been used to study the solid-state behavior of cysteamine hydrochloride and to report on its phase behavior as a function of pressure, temperature and humidity.
Experimental

Materials
Cysteamine hydrochloride was purchased from Sigma Aldrich (>98%) and used as such.
Because of its hygroscopicity, samples have been prepared in a glove box with a controlled humidity of less than 10%.
Thermogravimetry
Thermogravimetry (TGA) was carried out at various rates with a TGA50 thermobalance from TA-Instruments. No weight loss was observed in the range of 25 up to 100°C.
Differential scanning calorimetry
Differential scanning calorimetry (DSC) experiments were performed on a Q100 analyzer from TA Instruments (New Castle, DE, USA). Different quantities (2 to 10 mg) of cysteamine hydrochloride and different heating rates from 0.1 up to 10 K min -1 were used. The measurements were carried out on samples sealed in aluminum pans.
High-resolution X-ray powder diffraction
High-resolution X-ray powder diffraction patterns were obtained as a function of temperature from 120 K up to the liquid state with a CPS120 diffractometer from INEL (France) equipped with a liquid nitrogen 700 series Cryostream Cooler from Oxford Cryosystems (Oxford, UK). Data were collected for at least 1 hour per diffraction pattern. The heating rate between the measurements was 1.3 K min -1 and before data collection the sample temperature was left to stabilize for at least 15 min. The lattice parameters as a function of temperature have been determined with Pawley fits to the known unit cells using TOPAS Academic. 9
Crystal structure solution
For structure solution, the program DASH 10 and TOPAS-Academic 9 were employed and the powder pattern was truncated to 48.80° in 2ϑ (Cu Kα1), corresponding to a real-space resolution of 1.86 Å. The background was subtracted with a Bayesian high-pass filter. 11 Peak positions for indexing were obtained by fitting with an asymmetry-corrected pseudo-Voigt function. 12, 13 22 peaks were indexed with the indexing program DICVOL04. [14] [15] [16] ). Pawley refinement was used to extract integrated intensities and their correlations, from which the space group was determined using Bayesian statistical analysis. 17 The space group I2/a was returned as the most probable option, which was the space group with the highest symmetry. It resulted in a Pawley χ 2 of 5.23. Simulated annealing was used to solve the crystal structure from the powder pattern in direct space. The starting molecular geometry was taken from the published monoclinic structure (form I) from the CSD (reference code XIJKIK01). 18 In all 30 simulated annealing runs, the same crystal structure was found. The profile χ 2 of the best solution was 19.37, which is about four times the Pawley χ 2 ; these are good indications that the correct solution has been found.
Rietveld refinement
For the Rietveld refinement, data out to 71° 2θ were used, which corresponds to 1.33 Å realspace resolution. The Rietveld refinement was carried out with TOPAS-Academic. 9 Bond lengths, bond angles and planar groups were subjected to suitable restraints, including bonds to H atoms, based on the distances found in the structure XIJKIK01. A global Biso was refined for all non-hydrogen atoms, with the Biso of the hydrogen atoms constrained at 1. 
High-pressure thermal analysis
The transitions observed by DSC have been studied with high-pressure differential thermal analysis (HP-DTA). An in-house constructed HP-DTA, similar to the apparatus previously built by Würflinger 21 with temperature and pressure ranges from 203 to 473 K and 0 to 300 MPa, respectively, was used. Samples were sealed in cylindrical tin pans and to ensure that in-pan volumes were free from residual air, specimens were mixed with an inert perfluorinated liquid (Galden ® from Bioblock Scientifics, Illkirch, France) before sealing. HP-DTA scans were carried out with a heating rate of 2 K min -1 . In addition, DSC runs at ordinary pressure (i.e., in standard aluminum pans) with mixtures of cysteamine hydrochloride and perfluorinated liquid were carried out to verify that the latter was inert.
Differential vapor sorption
Differential vapor sorption (DVS) experiments have been carried out on a DVS-1000 of Surface Measurement Systems (SMS) London, UK. About 10 mg of cysteamine hydrochloride has been used in each experiment and relative humidities ranged from 0 to 90 %. The sample was considered stable with respect to the imposed water vapor once the fluctuation of its mass was below 0.001 mg.
Thermal expansion of the crystals
To investigate the thermal expansion of the crystal structures, all diffraction patterns belonging to a single series of measurements have been refined together in TOPAS-Academic 9 using Rietveld refinement of the known monoclinic structure with globally defined atom coordinates. In addition, the diffraction parameters such as the zero error and the slid width have each been refined with single variables for all patterns together. The unit cell parameters and peak shape parameters were allowed to refine freely.
The anisotropy of the intermolecular interactions can be investigated with the isobaric thermal expansion tensor, which is a measure of how the interactions change with temperature. 22 A small value for a tensor eigenvalue is commonly referred to as a "hard" direction and a large value as a "soft" direction. 23 The tensor has been calculated with the program PASCAL 24 and drawn with the program Wintensor. 25 
Results
Thermal behavior
Two endothermic thermal events have been observed for the commercial sample of cysteamine hydrochloride. The melting peak has an onset at 340.4 ± 0.5 K (67.3 °C) with a melting enthalpy of 141.6 ± 6.7 J g -1 ( Figure 2 ). Below the melting peak, another thermal event can be observed at around 322 K (49°C). The enthalpy change associated with this thermal event equals 9.9 ± 1.8 J g -1 . Cooling down directly after the appearance of the small peak does not lead to any exothermic events and on reheating the small peak does not reappear ( Figure 2 ). After melting and recrystallization at ambient temperature, only the melting peak is observed on reheating with comparable onset temperature and melting enthalpy ( Figure 2 ). The small peak depends on the heating rate of the DSC as can be observed in the inset of Figure 2 . At low scanning rates, 0.1 K min -1 , it tends to a minimum value of 310 K (37 °C). As thermogravimetric measurements demonstrated that the compound exhibits no weight loss on heating, the small peak is not related to any solvent or water loss. In the next section, it will be shown that this thermal event is linked to a solid-solid phase transition. by X-ray diffraction is in accordance with the temperature observed for the small peak by DSC, for which the minimum was found to be 310 K. Table 2 . A graph of the Rietveld refinement is presented in Figure 4a and the crystal packing is presented in Figure 4b . 
Crystal structure resolution of the new form III
Temperature dependence of the unit cell volumes of the different solid phases
The powder diffraction patterns of the commercial cysteamine hydrochloride sample have been fitted to the known monoclinic unit cell, form I, from 120 to 310 K. From the data in Table   SI .1 (Supporting Information) and the fact that Z = 4, 7 it follows that the specific volume of form I, vI(T) in cm 3 g -1 , as a function of the temperature in K can be written as:
This expression has an overall standard deviation of 4.2 ×10 −4 cm -3 g -1 for the temperature interval considered and a correlation coefficient of 0.997. In the diffraction patterns of form I as a function of temperature, no other forms have been observed.
From the data in Table SI .2 and the fact that Z = 8, it follows that the specific volume of form III, vIII(T) in cm 3 g -1 , as a function of the temperature in K can be written as:
The expression has an overall standard deviation of 5.6×10 −4 cm 3 g −1 within the temperature range of the data points and a correlation coefficient of 0.996. The relationship was obtained with data ranging from 120 K up to 335 K; however, the diffraction patterns below 200 K were mixed patterns of forms II and III. Thus, form II is the stable form below 200 K with respect to form III, otherwise it would not have formed.
Although there is much less data on the volume of the unit cell of the triclinic structure, for the sake of comparison, the following expression can be obtained from the unit cell volume valid within the range of 120 K up to 220 K (Table SI. 3, Z = 4):
with an overall standard deviation within the temperature range considered of 2.4×10 −4 cm 3 g -1
and a correlation coefficient of 0.999. Form II was still observed together with form III in a diffraction pattern obtained at 220 K in a heating run; this indicates that the transformation from II into III is slow, but that III must be the stable form at 220 K in respect to form II, otherwise it would not have appeared.
High-pressure differential thermal analysis of the I-III and melting transitions
By high-pressure differential thermal analysis, the I-III transition and melting temperatures have been measured as a function of pressure. The data is plotted in Figure 5 . At higher pressure, the onset temperatures of the solid-solid transition were difficult to determine in the DTA curves due to a flattened peak and low intensity and have been omitted.
The data has lead to the following expressions for the equilibrium curves as a function of pressure (MPa) and temperature (K):
with an overall standard deviation of 7.4 MPa and a correlation coefficient of 0.980.
III-L:
with an overall standard deviation of 10 MPa and a correlation coefficient of 0.984. Sensitivity of cysteamine hydrochloride to water is studied by means of differential vapor sorption (DVS). As a function of the relative humidity in the system maintained at a constant temperature of 25°C, the weight of cysteamine hydrochloride has been monitored. It can be seen in Figure 6 that there is no weight change of the drug sample up to 35% relative humidity, at which it abruptly starts to take up water. Thus, cysteamine hydrochloride is not hygroscopic up to 35 % relative humidity. liquid. This water quantity is extremely low. The proximity to the 1:1 ratio gave rise to the initial suspicion that a transitory hydrate was formed, but as stated above, X-ray diffraction did not provide any evidence for this hypothesis.
Differential vapor sorption and solubility
As no hydrates have been observed in the water -cysteamine hydrochloride system, its binary phase diagram must consist of a simple eutectic system. The composition of such a system as a function of temperature can be determined relatively easily by differential scanning calorimetry. Mixtures of different composition in water and cysteamine hydrochloride give in most cases rise to two peaks as a function of temperature. The lowest peak is the formation of the mixed liquid or eutectic liquid and a higher, generally shallower peak is caused by the dissolution of the remainder of the solid phase into the liquid; the highest temperature, at which the last part of the solid dissolves, is called the liquidus. A single peak is found in the binary system when its composition is exactly that of the eutectic liquid. Examples of DSC traces can be found in Figure 7 and the resulting binary phase diagram in Figure 8 , in which it can be seen that the eutectic temperature is found at 240 K. In addition to the liquidus temperatures obtained by In the results section the crystal structure of the new form III has been solved. Its structure will be compared in this section with the reported structures of forms I and II, which have been mentioned in the introduction (Table 1) . 6, 7 Cysteamine has only a single torsion angle disregarding the hydrogen atoms ( Figure 9 ). In all the 3 solid forms, the conformation of the bonds, the most stable having a gauche conformation around the N-C-C-S torsion, which is stabilized by an intramolecular hydrogen bond between the thiol and the amino group. 27 Although this hydrogen bond will not form with the ammonium group in cysteamine hydrochloride, in all three crystal structures the conformation around the N-C-C-S torsion angle remains gauche. That gauche is also the preferred conformation of charged cysteamine in solution is confirmed by a study of cysteamine by Raman spectroscopy. 28 In solid form III, the asymmetric unit contains one protonated cysteamine moiety and a chloride ion, like in form I, whereas in form II Z' equals 2. The molecular packing of form III is presented in Figure 4b above. It consists of layers with alternating protonated cysteamine and chloride ions parallel to the bc plane of the unit cell. Similar layers are observed in form I and form II. Within the layers the amino groups are facing each other forming a strong square shaped hydrogen-bond motif with two chloride ions (see Figure 10) . This square or slightly diamond shaped hydrogen-bond motif (graph set R 2 4(8)) clearly containing a strong ionic component is approximately parallel to the diagonal of the ab plane of the unit cell in form III.
The thiol group faces in the same direction as the amino group, thus it is the ethane backbone that interconnects the layers of molecules joined by the square-shaped hydrogen bond interaction ( Figure 10 ) mainly by interactions between hydrogen atoms and the chloride ion.
This pattern is similar in all three forms; the principal difference is the conformation of the cysteamine molecule ( Figure 9 ). In all three forms, the three protons of the terminal ammonium group are involved in hydrogen bonds with different chloride ions (Table 3 ). In addition, the chloride ions are also involved in weaker hydrogen-bond type interactions with CH2 groups. This feature exists in all three structures as can be seen in Figure 11 . In forms I and III, a small uniaxial negative thermal expansion is observed along e1 (Table 4 ).
This direction coincides in both crystal forms with the alignment of the ammonium groups involved in the square-shaped hydrogen-bond motif (graph set R 2 4(8)) with strong ionic character. The two chloride ions in this motif are more or less aligned along e2. Considering the fact that the tensor in the e2 direction is very similar between form I and form III (Table 4) Although the unit-cell volumes of the three solid phases have been determined as a function of the temperature with high-resolution X-ray diffraction, it has not been possible to determine the volume inequalities between the three phases ( Figure 12 ). The volume differences are smaller than the resolution of the measurements, as is clear from the overall standard deviations provided with the fits of the specific volumes (eqs. 1-3). However, using the experimental highpressure thermal analysis data, one can see that the slope of the I-III equilibrium is 59 ±5 MPa K -1 (equation (4) and Figure 5 ). It is also known from the DSC results that the enthalpy difference between the two solid phases equals 9.9 ± 1.8 J g -1 . In addition, the transition temperature has been found at 310 ± 1 K (37 °C). These values can be inserted into the Clapeyron equation to evaluate the volume difference between form I and form III:
The slope of the I-III equilibrium and their volume inequality
with dP/dT the slope of a two-phase equilibrium in the pressure -temperature phase diagram in MPa K -1 , ΔS the entropy difference between the two phases in equilibrium, ΔV the volume inequality between the two phases in equilibrium. At equilibrium, ΔS can be replaced by ΔH/T, the enthalpy difference divided by the transition temperature obtained by calorimetry.
Using expression 7, the volume difference between forms I and III can be calculated and it follows that ΔI →III v = 5.4(1.1)×10 −4 cm -3 g -1 . This implies that the volume difference going from form I to form III is positive, thus form III would have a slightly larger volume than form I.
However, it is also clear that the volume inequality is of the same order of magnitude as the global fitting errors of the expressions for the specific volumes of forms I and III (4.2 ×10 −4 cm -3 g -1 and 5.6×10 −4 cm 3 g −1 respectively for eqs. 1 and 2). Thus, it can merely be stated that the volume change is very small and most likely positive going from form I to form III. The steep slope of the equilibrium line ( Figure 5 ) implies that the transition is mainly heat or entropy driven, as its dependence on the pressure is very weak, which is equivalent to the observation that the volume change between the two solid phases is very small.
Pressure-temperature curve of the solid -liquid equilibrium III-L
The slope of the HP-DTA measurements equals 11.5 ±0.5 MPa K -1 (eq. 5). At the transition temperature 340.4 ±0.5 K (67.3 °C), the enthalpy change associated with the transition equals 141.6 ±6.7 J g -1 . The volume of form III is known at the melt and equals 0.766 cm 3 g -1 using equation eq. 2. As in the previous section, the experimental slope of the solid -liquid equilibrium allows the calculation of the volume inequality between the liquid phase and form III, which leads to ΔIII →L v = 0.0361 ±0.0026 cm 3 g -1 , which in turn leads to the specific volume of the liquid at the melting point, 0.802 ±0.005 cm 3 g -1 . This is an increase of 4.7 % in volume on melting, which is fairly small in comparison with most pharmaceutical systems, where the average difference is in the order of 11%. 32, 33
The topological pressure-temperature phase diagram involving form I, form III and the liquid 4.4.1 What is a topological phase diagram
A topological phase diagram is a schematic representation of the domains of the stable phases and their phase relationships. It can be extended to the metastable and supermetastable phase domains because from a thermodynamic point of view these are simply states with a higher Gibbs energy that eventually may lose their excess Gibbs energy to turn into the most stable state spontaneously. There is no rule stating in which timeframe this will occur. A wellknown example is the allotropic forms diamond and graphite of which graphite is the most stable phase under ambient conditions. This has not stopped anyone from spending lots of money on the less stable diamond and neither are we concerned that diamond will convert into graphite in our lifetime.
The topological phase diagram will be constructed with as much available experimental data possible; however, in the case that data is lacking e.g. a melting point of a metastable phase or triple points under very high or negative pressure, use will be made of extrapolations and calculations, which are thermodynamically sound, even if they may be approximate. It should be kept in mind that the main goal of this topological phase diagram is to demonstrate the relative positions of the different phase domains towards each other as a function of pressure and temperature and those of the two-phase equilibria, which represent the boundaries between the domains. The more experimental data available, the more accurate will be the phase diagram;
however, certain parts of it may remain approximate. 
Phase equilibria I-III, III-L and I-L
In section 3.3, the expressions for the phase equilibria I-III (eq. 4) and III-L (eq. 5) have been determined. The expression for the metastable phase equilibrium I-L is not known however because the melting of phase I has not been observed and it will be obtained by calculation and extrapolation below.
As can be seen in Figure 5 , phase equilibria of condensed phases on the pressuretemperature plane can be represented over a reasonable pressure-temperature interval as straight lines. In any case, phase equilibria are monotonously increasing functions due to the fact that the Gibbs energies involved are monotonous surfaces as a function of pressure and temperature. 34, 35 The simplest approximation of a monotonously rising function is a straight line. To obtain a linear expression for the phase equilibrium I-L, the metastable melting of form I, two points in the pressure-temperature domain need to be found on the I-L equilibrium line. The two points that will be used are I-L-V and I-III-L, two triple points containing the I-L equilibrium.
Even though the melting point of form I is not observed by DSC as it converts into form III before melting, thermodynamically the equilibrium between form I and the liquid exists as a metastable equilibrium for which the temperature can be determined using an expression obtained from thermodynamics and neglecting heat capacities [36] [37] [38] : (8) Here TI →L is the melting point of form I in kelvin, ∆III →L H is the melting enthalpy of form III and TI →III is the temperature at which forms I and III are in equilibrium. The other two variables follow the same nomenclature. Using the calorimetric data presented in the results section, one finds 338.3 K (65.1 °C), thus just below the observed melting point. Because form I is metastable at its melting point it cannot melt at a higher temperature than form III. The close proximity of the two melting points justifies neglecting the heat capacities. 37 The pressure at the melting temperature will depend on the vapor pressure of the condensed phases of the I-L equilibrium in the DSC pan. Because the available volume in sealed DSC pans is small, the saturated vapor pressure will be quickly reached; thus, the melting transition, implying the equilibrium between solid I and the liquid occurs in equilibrium with the vapor phase and this is therefore a triple point, in the present case I-L-V. The vapor pressure of solid or liquid cysteamine hydrochloride has not been measured to our knowledge, but because it is a salt, it must be very low, not higher than a few pascal and most likely lower. Thus the coordinates of the triple point I-L-V can be considered to be approximately 338 K, 1 Pa.
The second triple point that will be used to determine the position of the I-L equilibrium line is I-III-L. It can be seen that equilibria I-III and III-L must intersect at this triple point too.
Because the expressions for the latter two equilibria are known (eqs. 4 and 5), setting those expressions equal to each other allows to find the temperature of the triple point and the pressure follows from either eqs. 4 or 5. This leads to the coordinates 314 K, −309 MPa.
Obviously, these coordinates are obtained by approximation using straight lines and their values are not accurate, however, they suffice to obtain an expression for the two-phase equilibrium I-L. It can be observed that the pressure of the triple point is negative. One should be aware that in these calculations negative pressure is mainly used as a mathematical approach; however negative pressure is a physical reality as can be judged from the following references. 34, 39, 40 With the forgoing coordinates obtained for the triple points I-III-L and I-L-V a straight line can be fitted and the following approximate expression for the I-L equilibrium in the pressuretemperature phase diagram can be obtained:
Assuming that the specific volume of the melt does not change much within the two degrees difference between the two melting points (I-L Figure 13 with all equilibrium lines and triple points obeying the alternation rule.
As the transition I-III is stable, both form I and form III must have a stable domain too.
Because the I-III equilibrium and the III-L equilibrium are positive and diverge with increasing pressure (Figures 5 and 13 ) the two phases have an overall enantiotropic phase relationship. 42, 43 As for the triclinic form II (absent in this phase diagram), only the specific volume is known as a function of temperature between 100 and 200 K. The fact that II appeared at low temperature during the measurements indicates that it is more stable than form III at low temperature, but the transition temperature is not known. It is therefore not yet possible to incorporate form II in the present phase diagram. Nonetheless, the stability hierarchy between forms I and III determined in this paper will not be affected once form II is added to the phase diagram. 
Stability with respect to water
In the results section, it has been found that cysteamine hydrochloride forms a eutectic equilibrium with water. In principle, it is possible to calculate the entire eutectic phase diagram once the eutectic temperature and a few temperature points on the liquidus line have been obtained. However, the present system has the complication of the phase change with increasing temperature. Considering the DVS curve in Figure 6 , the presence of a small amount of water (Figure 14a ). At the water-rich side, the pressure of the system is determined by the vapor pressure of pure water, which is higher than that of cysteamine hydrochloride as a function of temperature. Thus, taking the pressure coordinate into account, the projected T-x diagram in Figure 8 is actually shifted in relation to the vapor pressure of the system as schematically indicated in Figure 14a . Moreover, in P-T-x coordinates the T-x slice projected on the T-x plane in Figure 8 exhibits a curvature with increasing temperature due to the increase of the combined vapor pressure of the binary system (Figure 14a ).
In Figure 14a the pressure component is simplified, because a full representation cannot be clearly presented in 3 dimensions; the present P-T-x diagram is a depiction of the condensed phases neglecting the vapor phase. The related P-x behavior during the DVS measurement at 25
°C has been provided in Figure 14b . The trace of the DVS measurement has also been indicated in Figure 14a by a dotted line. In Figure 14b , it can be seen that while the water vapor pressure Figure 6 , the numbers have also been provided on the DVS curve).
Solution 4 is in equilibrium with vapor mixture 5 very rich in water.
Conclusions
A new solid form of cysteamine hydrochloride has been discovered and its crystal structure, the monoclinic spacegroup I2/a, has been determined by X-ray powder diffraction. All three known crystal structures of cysteamine hydrochloride have a very similar interaction make-up.
The new solid form III is stable above 310 K, but persists at lower temperatures as can be It is clear that cysteamine hydrochloride is hygroscopic and water increase is substantial when the relative humidity rises above 35%. In fact above this water vapor pressure, cysteamine hydrochloride liquefies immediately to form a very concentrated saturated solution of 47.5 mole% in water. Also considering the low eutectic temperature of 240 K, it is clear that any presence of water, will basically cause cysteamine hydrochloride to dissolve. There is no evidence for the existence of a hydrate with cysteamine hydrochloride.
The present paper combines the results of measurements on the unary system with those on cysteamine hydrochloride with water. It has been shown how these different elements can be combined to improve the understanding of the system, for example for the calculation of the liquidus in the temperature -composition phase diagram.
From a pharmaceutical point of view, the findings imply that form I would be the best form to develop, as it appears to be the most stable form under ambient conditions. However, if cysteamine hydrochloride is subjected to temperatures above 40°C for a sufficient amount of time, which would only be a couple of hours, the compound may transform into form III and persist in that form when the temperature comes down to room temperature (It is not known for how long form III persists at room temperature). For formulations, this will probably have very little effect, as the volume of both phases is virtually the same. The persistence of form III under ambient conditions may however slightly increase solubilization, as form III is less stable than form I under ambient conditions.
The samples should be strictly protected against water, as a saturated solution of water and cysteamine hydrochloride forms under low water-vapor pressures. In the concentrated solution, degradation may occur among others by formation of cystamine dihydrochloride. The susceptibility to water implies that cysteamine hydrochloride should be stored in a dry environment and also that refrigeration should be avoided; cold samples will attract water by condensation and immediately form saturated solution.
